Stonepine Capital Management, LLC Portfolio Holdings

Stonepine Capital Management, LLC

  • $123 Billion
  • Q3 2025

Stonepine Capital Management, LLC has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $123 Billion distributed in 58 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verastem Inc with a value of $23.6B, Adma Biologics, Inc. with a value of $10.8B, Evolus, Inc. with a value of $9.43B, Kempharm, Inc with a value of $7.7B, and Nektar Therapeutics with a value of $4.84B.

Examining the 13F form we can see an increase of $21.1B in the current position value, from $102B to 123B.

Stonepine Capital Management, LLC is based out at Bend, OR

Below you can find more details about Stonepine Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $123 Billion
Healthcare: $69.2 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 58
  • Current Value $123 Billion
  • Prior Value $102 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 13, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 19 stocks
  • Additional Purchases 23 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 16 stocks
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email